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A 64 kDa protein has been identified in the membrane fraction of human eye muscle, orbital connective tissue and 
thyroid, by testing sera of patients with thyroid-associated ophthalmopathy in SDS-polyacryltide gel electrophoresis 
and Western blotting. Antibodies to this membrane antigen seem characteristic of the early stage of ophthahnopathy. 
In the thyroid this newly recognixed protein seems different from previously known membrane antigens. A thyroid anti- 
body reactive with a 64 kDa membrane antigen in eye muscle could explain the very frequent association of ophthalmop- 
athy with autoimmune thyroid disease. 
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1. INTRODUCTION 
Cytotoxic antibodies directed against an eye 
muscle cell surface antigen in antibody-dependent 
cell-mediated cytotoxicity (ADCC) have been iden- 
tified in the serum of patients with thyroid- 
associated ophthalmopathy (TAO) [l]. These an- 
tibodies were demonstrated to be cross-reactive 
with an antigen in thyroid membranes, which was 
not recognized by a monoclonal antibody reactive 
with thyroid peroxidase (TPO) [2], now known to 
be the thyroid ‘microsomal’ antigen [3]. Here, we 
have investigated the nature of eye muscle (EM), 
orbital connective tissue (OCT) and thyroid (THY) 
antigens which are targets for autoantibodies in the 
sera of patients with TAO, using SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western blotting. We were able to identify a 
previously unrecognized 64 kDa protein in eye 
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muscle, orbital connective tissue and thyroid mem- 
branes against which autoantibodies, in the serum 
of patients with TAO but not normal subjects, 
react. 
2. MATERIALS AND METHODS 
2.1. Patients 
We studied 47 patients, 43 women and 4 men (19-65 years 
old; mean, 44 years), with thyroid-associated ophthalmopathy 
of whom 40 had Graves’ hyperthyroidism and 7 Hashimoto’s 
thyroiditis. The clinical severity of the eye disease was assessed 
using a ‘clinical index’ based on the classification recommended 
by the American Thyroid Association [4]. The disease was ac- 
tive in 37 patients and inactive (‘burnt out’) in 10. All patients 
had class 3 or worse disease. The eye disease was also classified 
according to its duration, i.e. the time, at testing, since the onset 
of symptoms and signs. The ophthalmopathy was assessed as (i) 
recent, if present for less than 12 months; (ii) ‘chronic’, if pre- 
sent for l-3 years; or (iii) burnt-out, if present for more than 
3 years, and inactive. We also studied (i) 16 patients, 9 women 
and 7 men (20-67 years old; mean, 35 years), with Graves’ 
hyperthyroidism (GH); (ii) two patients, one 45year-old 
women and one 36-year-old man, with Hashimoto’s thyroiditis 
(HT), neither of whom had clinically evident eye involvement; 
and (iii) 12 normal subjects, 9 women and 3 men (18-67 years 
dd; mean, 38 years), as controls. 
Published by Eisevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 135 
Volume 232, number 1 FEBS LETTERS May 1988 
2.2. Antigen preparation 
Normal human EM and OCT were obtained from 3 subjects 
at autopsy less than 5 h after death. Normal human THY tissue 
was obtained at thyroidectomy from a patient undergoing 
surgery for removal of a nontoxic nodular goiter. Skeletal mus- 
cle @KM) and skin connective tissue (SKCT) specimens were 
also obtained at autopsy as control antigens. Membrane frac- 
tions were prepared from homogenates by centrifugation at 800 
x g for 15 min, to remove debris, then centrifuging the pellet 
at 10000 x g for 60 min, or at 100000 x g for 60 mitt, to obtain 
the cell membrane fraction and microsomes, respectively. 
2.3. SDS-PAGE and Western blotting 
The polyacrylamide gel used was 10% running gel and 5% 
stacking gel. Antigen preparations were applied at a concentra- 
tion of 300 pg protein in lOO-~1 aliquots per well. In each experi- 
ment molecular mass standards (Rainbow Mix, Amersham, 
Arlington Heights, IL) were included. The gel was run at 7 mA 
overnight, then transferred onto nitrocellulose paper at 45 V 
for 4.5 h in transfer buffer (0.02 mol/l Trizma base, 0.2 mol/l 
glycine in 20% methanol-80% distilled water; pH 8.3). One 
strip was stained with amido black and destained with 5% 
methanol, 7% acetic acid in distilled water to show antigen 
bands. The strips were incubated in 2.5% BSA or 2% gelatin 
in phosphate-buffered saline (PBS), pH 7.4, at room temper- 
ature for 60 min, washed in Trizma-buffered saline (TBS: 
0.2 mmol/l Tris-HCI, 0.9% NaCI; pH 7.4) for 30 min then in- 
cubated with patient or normal sera, diluted 1: 50 in 0.1 “/o BSA- 
PBS, for 3 h at room temperature. PBS was used instead of 
serum for control strips. The paper was then washed with TBS 
and incubated with a horseradish peroxidase-conjugated anti- 
human IgG (H + L), diluted 1: 1500 in 0.1% BSA-PBS, for 2 h 
at room temperature. Strips were again washed with TBS and 
developed with 3,3 ’ -diaminobenzidine tetrahydrochloride 
dihydrate 97% (DAB) (Aldrich, Milwaukee, WI) at 0.5 mg/ml 
concentration in PBS. Finally, strips were washed with distilled 
water for 5 min to remove excess DAB and dried on absorbing 
paper. 
2.4. Cell culture and antibody-dependent cell-mediated 
cytotoxicity 
These methods have been detailed previously [l]. Briefly, 
fresh normal human eye muscle, obtained at surgery from 
children undergoing strabismus repair, was cultured and grown 
as cell monolayers. A standard antibody-dependent cell- 
mediated cytotoxicity (ADCC) assay, incorporating 5’Cr- 
labelled eye muscle cells, unfractionated peripheral blood lym- 
phocytes at a 25: 1 effecter/target cell ratio as effector cells, 
and heat-inactivated patient’s serum at a dilution of 1: 20, was 
used to test cytotoxicity. Results were expressed as % specific 
lysis, calculated from: cpm test - cpm spontaneous/cpm 
total - cpm spontaneous x 100 (minus natural killer cell lysis). 
2.5. Antimicrosomal and antithyroglobulin antibody assays 
Antimicrosomal and antithyroglobulin antibodies were tested 
for by the passive hemagglutination assay using commercial kits 
(Wellcome, Beckenham, England). 
2.6. Statistical analysis 
Two-variable ,$ analysis was used to test the significance of 
the difference in frequencies of a 64 kDa band between patient 
and control groups. 
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3. RESULTS 
SDS-PAGE and Western blotting analysis of 
normal and patient sera was performed using 
various thyroid and orbital tissue membranes. A 
prominent band in one or more of thyroid, eye 
muscle and orbital connective tissue membranes, 
at approx. 64 kDa (figs 1,2), was seen with the 
serum of 26 out of 47 patients with TAO, but with 
that of only three of 15 patients with Graves’ 
hyperthyroidism without apparent eye involve- 
ment k2 test, P < 0.02) and with none of the 12 
normal subjects tested as controls h2 test, P < 
0.01) (table 1). The band was present in eye muscle 
membranes only, in tests with serum from 10 pa- 
tients, in orbital connective tissue membranes on- 
ly, with serum from one patient, and associated 
with a similar band in two or more of eye muscle, 
orbital connective tissue and thyroid in with serum 
from 14 patients (54%). Sera from 8 patients also 
recognized a 64 kDa protein in skeletal muscle and 
in six of them there was a reaction with a 64 kDa 
protein in eye muscle. In the case of two patients 
with TAO whose serum gave a 64 kDa band in skin 
connective tissue, a corresponding band was also 
recognized in eye muscle, thyroid and skeletal mus- 
cle in both cases. Other less prominent bands at 50, 
21.5kC 
kl.4Kd- 
Fig. 1. Reactivity with a 64 kDa protein of serum from patients 
with thyroid-associated ophthalmopathy, determined by SDS- 
PAGE and Western blotting. Lanes: 1, 100000 x g preparation 
of human thyroid membranes; 2, 10000 x g preparation of 
thyroid membranes; 3, 100000 x g preparation of orbital 
connective tissue membranes; 4, 100000 x g preparation of 
human eye muscle membranes. S, molecular mass standards. 
A-C show reactivity with sera from three patients with 
ophthalmopathy. 
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1234 1234 1234 Table 2 
Reactivity with a 64 kDa protein in thyroid, human eye muscle, 
and’orbital connective tissue membranes, as shown by SDS- 
PAGE electrophoresis and Western blotting, and thyroid 
antibody titers, with serum from patients with thyroid- 
associated ophthalmopathy 
46Kd- 
Patient Membrane Thyroid antibody 
preparation titer8 
THY EM OCT AMA ATA 
CH +b + + 1:25600 neg 
SP + + + neg neg 
JT + + _ 1:lOO neg 
ML + + - 1: 100000 neg 
LS + + _ 1:lOO neg 
CR + + - neg neg 
RV + + - 1: 1600 neg 
a Antimicrosomal antibody titer; antithyroglobulin antibody 
titer 
b A 64 kDa band was shown in SDS-PAGE and Western 
blotting with the patient’s serum 
S A s C 
Fig.2. As in fig.1 except hat (lanes) 1, eye muscle membranes; 
2, orbital connective tissue membranes; 3, thyroid membranes 
(all 100000 x g preparations) and A-C show reactivity with 
sera from a normal subject and two other patients with thyroid- 
associated ophthalmopathy, respectively. 
58 and 85 kDa, were also occasionally found in 
tests with sera from patients with autoimmune 
thyroid disorders with or without ophthal- 
mopathy. 
Reactivity with a 64 kDa thyroid membrane pro- 
tein was demonstrated with sera from 9 patients 
with TAO. In all cases the band was also present 
Table 1 
Prevalence of serum reactivity with a 64 kDa protein in human 
thyroid and orbital tissue membranes, as shown by SDS-PAGE 
and Western blotting, in patients with autoimmune thyroid 
disorders and ophthalmopathy 
Tissue Group 
(n =l7) (nZ5) (nH_T2) 
NOR 
(n = 12) 
EM 24(10) 3(2) 0 0 
OCT 7(l) l(0) 0 0 
THY 9(O) 0 0 0 
1261 131 WI 101 
x2 test, x2 test, 
GH vs GO NOR vs GO 
P < 0.02 P < 0.01 
EM, eye muscle; OCT, orbital connective tissue; THY, thyroid; 
GO, Graves’ ophthalmopathy; GH, Graves’ hyperthyroidism; 
HT. Hashimoto’s thyroiditis; NOR, normal subjects. ( ), 
number of patients in whom the 64 kDa band was 
demonstrated only in that tissue; is shown in parentheses. [ 1, 
total number of patients in whom the 64 kDa band was 
demonstrated in at least one tissue 
in one or both orbital tissue preparations. As can 
be seen in table 2, in these patients the finding of 
a 64 kDa band was not related to the detection or 
titers of antimicrosomal or antithyroglobulin an- 
tibodies. A band at 105 kDa in thyroid mem- 
branes, corresponding to the microsomal (TPO) 
antigen, was detected in tests with serum from 
three patients with TAO. 
Sera from 3 1 of the patients with TAO were also 
tested, in ADCC assay, for cytotoxic antibodies 
against eye muscle cells. Although 12 of the 19 sera 
giving a positive ADCC test were shown to 
recognize the 64 kDa protein in eye muscle mem- 
Table 3 
Prevalence of reactivity with a 64 kDa protein in human eye 
muscle membranes, as shown by SDS-PAGE and Western 
blotting, in relation to the duration of eye disease, with the 
serum of patients with thyroid-associated ophthalmopathy 
Duration of 
ophthalmopathy 
Number of patients showing 
reactivity with a 64 kDa 
proteina 
< 1 year 24 (65%) 
(?I = 37) 
> 1 year 3 (30%) 
(n = 10) ,$ test, P < 0.05 
’ Determined from SDS-PAGE and Western blotting 
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branes, 8 of the 12 ADCC negative sera also 
reacted with this protein, and the difference was 
not significant (x2 test, P = NS). 
Finally, the prevalence of detectable reactivity 
with a 64 kDa protein, as determined from SDS- 
PAGE and Western blotting, was correlated with 
the duration of the ophthalmopathy. The results 
are summarized in table 3. The band was found in 
a significantly higher proportion with patients’ 
sera obtained during the first 12 months of the eye 
disease (24 out of 37) compared to that with sera 
obtained more than 1 year after the onset (3 of 10, 
x2 tests, P < 0.05). 
4. DISCUSSION 
In this study, using SDS-PAGE and ‘Western 
blotting, we have confirmed the existence of au- 
toantibodies in the serum of patients with thyroid- 
associated ophthalmopathy which are directed 
against membrane antigens in human eye muscle, 
orbital connective tissue and the thyroid. Among 
these antigens, a 64 kDa protein present in the 
membrane fraction of orbital tissue, and also ex- 
pressed in the thyroid, appears of major relevance 
to the pathogenesis of TAO. Recently, Ahmann et 
al. [5] reported the presence of heterogeneous and 
non-specific antigen determinants of 50, 64 and 
73 kDa in porcine eye muscle membranes as deter- 
mined by reactivity, in SDS-PAGE, with an- 
tibodies in the serum of patients with Graves’ 
disease, with or without eye disease, but also of 
normal controls. Bahn et al. [6] identified a 
23 kDa antigen in orbital connective tissue when 
the serum of TAO patients was tested in SDS- 
PAGE incorporating orbital fibroblasts. In- 
terestingly, autoantibodies to a 64 kDa pancreatic 
islet cell protein have also been reported in newly 
diagnosed diabetic children [7] although the 
authors were not able to determine whether this 
was an intracellular or a cell surface component. In 
the present study the detection of antibodies reac- 
tive with a 64 kDa membrane protein was 
significantly associated with the presence of 
ophthalmopathy, in particular when the disease 
was of recent onset and active. 
The existence of antibodies reactive with a 
64 kDa antigen in two or more of thyroid, eye 
muscle and orbital connective tissue membranes, 
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in 50% of TAO sera tested, suggests that the same 
protein is present in all three tissues and (perhaps 
also in skin, other skeletal muscle and pancreas) 
and that the antibodies may be cross-reactive. 
Failure to demonstrate a band, at 64 kDa, in all 
three tissues with all sera reacting with at least one 
membrane preparation tested, may be due to the 
variable expression of the antigen on the different 
membrane preparations used. Indeed, in the pre- 
sent study, positive sera occasionally gave negative 
results when tested with membranes prepared from 
a different normal subject. Absorption ex- 
periments, currently in progress, are needed to 
confirm the presence of cross-reactive antibodies 
[8] and to determine the full tissue distribution of 
the 64 kDa protein. 
We have also confirmed the existence of a 
previously unrecognized thyroid-directed an- 
tibody, reacting with a 64 kDa membrane antigen 
which seems to be different from other known 
thyroid membrane antigens such as TPO [3] and 
the TSH receptor [9]. A cytotoxic antibody, reac- 
tive with a cell surface antigen expressed on both 
eye muscle and thyroid cells, has been recently 
described by our group [2]. Furthermore Hari et 
al. [lo] produced a cytotoxic monoclonal an- 
tibody, reactive with a 64 kDa pancreatic islet cell 
surface protein, from lymphocytes of non-obese 
diabetic mice, leading them to postulate an ADCC 
mechanism in the pathogenesis of type I diabetes. 
In our study the presence of 64 kDa protein- 
reactive antibodies in the serum of patients with 
TAO did not correlate with positive ADCC activity 
against eye muscle cells. In order to determine the 
clinical and pathogenetic significance of antibodies 
reactive with the 64 kDa protein we are testing, in 
a prospective study, ADCC and complement- 
mediated killing of eye muscle and thyroid cells, 
and performing SDS-PAGE with membrane 
preparations of these tissues, on the sera of newly 
diagnosed patients with Graves’ hyperthyroidism, 
some of whom are expected to develop 
ophthalmopathy during the course of the study. 
The existence of a cytotoxic thyroid antibody 
directed against a cell wall derived 64 kDa protein 
which is also expressed on eye muscle cells, and 
perhaps orbital fibroblasts, would certainly offer a 
plausible explanation for the very close association 
of ophthalmopathy with autoimmune thyroid 
disorders [8]. 
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